CIK: 0001595851 · Show all filings
Period: Q2 2016 (← Previous) (Next →)
Filing Date: Aug 12, 2016
Total Value: $346M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IWM | ISHARES TR | 350,000 | $40.24M | 11.6% | — | — | Put | 464287655 |
| XBI | SPDR SERIES TRUST | 400,000 | $21.63M | 6.2% | — | — | Put | 78464A870 |
| SPY | SPDR S&P 500 ETF TR | 100,000 | $20.95M | 6.0% | — | — | Put | 78462F103 |
| — | GW PHARMACEUTICALS PLC | 130,000 | $11.9M | 3.4% | — | — | Put | 36197T103 |
| — | OPHTHOTECH CORP | 215,000 | $10.97M | 3.2% | $46.14 | — | COM | 683745103 |
| — | ALEXION PHARMACEUTICALS INC | 90,000 | $10.51M | 3.0% | $126.74 | — | COM | 015351109 |
| — | NUVASIVE INC | 150,000 | $8.958M | 2.6% | $53.61 | — | COM | 670704105 |
| MDT | MEDTRONIC PLC | 100,000 | $8.677M | 2.5% | $62.28 | +2.0% | SHS | G5960L103 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 110,000 | $8.558M | 2.5% | $83.69 | +1.6% | COM | 09061G101 |
| EW | EDWARDS LIFESCIENCES CORP | 85,000 | $8.477M | 2.4% | $34.21 | 0.0% | COM | 28176E108 |
| CNMD | CONMED CORP | 175,000 | $8.353M | 2.4% | $38.21 | 0.0% | COM | 207410101 |
| — | ACORDA THERAPEUTICS INC | 325,000 | $8.289M | 2.4% | $25.50 | — | COM | 00484M106 |
| BSX | BOSTON SCIENTIFIC CORP | 350,000 | $8.18M | 2.4% | $17.57 | +23.2% | Call | 101137107 |
| BSX | BOSTON SCIENTIFIC CORP | 325,000 | $7.595M | 2.2% | $17.57 | +23.2% | COM | 101137107 |
| — | AXOVANT SCIENCES LTD | 575,000 | $7.383M | 2.1% | $12.84 | — | COM | G0750W104 |
| — | BLUEBIRD BIO INC | 170,000 | $7.359M | 2.1% | $43.29 | — | COM | 09609G100 |
| BIIB | BIOGEN INC | 30,000 | $7.255M | 2.1% | $263.54 | 0.0% | COM | 09062X103 |
| — | SPECTRANETICS CORP | 375,000 | $7.016M | 2.0% | $13.55 | — | COM | 84760C107 |
| — | CLOVIS ONCOLOGY INC | 500,000 | $6.86M | 2.0% | $13.94 | — | Put | 189464100 |
| — | CLOVIS ONCOLOGY INC | 450,000 | $6.174M | 1.8% | $13.94 | — | COM | 189464100 |
| — | NEVRO CORP | 80,000 | $5.901M | 1.7% | $67.90 | — | COM | 64157F103 |
| SRPT | SAREPTA THERAPEUTICS INC | 300,000 | $5.721M | 1.7% | $18.47 | 0.0% | Put | 803607100 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 125,000 | $5.681M | 1.6% | $46.04 | 0.0% | COM | 64125C109 |
| — | LION BIOTECHNOLOGIES INC | 700,000 | $5.67M | 1.6% | $7.02 | — | COM | 53619R102 |
| — | K2M GROUP HLDGS INC | 350,000 | $5.432M | 1.6% | $15.52 | — | COM | 48273J107 |
| — | GENOMIC HEALTH INC | 200,000 | $5.179M | 1.5% | $25.89 | — | COM | 37244C101 |
| — | INTERCEPT PHARMACEUTICALS IN | 35,000 | $4.994M | 1.4% | $142.68 | — | Call | 45845P108 |
| — | ENDOLOGIX INC | 400,000 | $4.984M | 1.4% | $12.46 | — | COM | 29266S106 |
| BCRX | BIOCRYST PHARMACEUTICALS | 1,700,000 | $4.828M | 1.4% | $3.10 | 0.0% | COM | 09058V103 |
| — | INTRA CELLULAR THERAPIES INC | 120,000 | $4.658M | 1.3% | $38.82 | — | COM | 46116X101 |
| — | SAGE THERAPEUTICS INC | 150,000 | $4.52M | 1.3% | $56.65 | — | Call | 78667J108 |
| — | WRIGHT MED GROUP N V | 250,000 | $4.343M | 1.3% | $20.78 | — | ORD SHS 0.03 PAR | N96617118 |
| — | TESARO INC | 50,000 | $4.203M | 1.2% | $84.06 | — | Call | 881569107 |
| — | TESARO INC | 50,000 | $4.203M | 1.2% | $84.06 | — | COM | 881569107 |
| — | HORIZON PHARMA PLC | 250,000 | $4.118M | 1.2% | $16.57 | — | SHS | G4617B105 |
| PCRX | PACIRA PHARMACEUTICALS INC | 120,000 | $4.048M | 1.2% | $49.15 | 0.0% | COM | 695127100 |
| SRPT | SAREPTA THERAPEUTICS INC | 200,000 | $3.814M | 1.1% | $18.47 | 0.0% | COM | 803607100 |
| — | FLAMEL TECHNOLOGIES SA | 350,000 | $3.759M | 1.1% | $10.74 | — | SPONSORED ADR | 338488109 |
| — | HORIZON PHARMA PLC | 200,000 | $3.294M | 1.0% | $16.57 | — | Call | G4617B105 |
| — | RAPTOR PHARMACEUTICAL CORP | 600,000 | $3.222M | 0.9% | $5.37 | — | COM | 75382F106 |
| — | NANOSTRING TECHNOLOGIES INC | 250,000 | $3.15M | 0.9% | $13.19 | — | COM | 63009R109 |
| — | CELGENE CORP | 25,000 | $2.466M | 0.7% | $100.09 | — | COM | 151020104 |
| — | IMMUNOMEDICS INC | 1,000,000 | $2.32M | 0.7% | $2.32 | — | COM | 452907108 |
| — | ENTELLUS MED INC | 120,000 | $2.192M | 0.6% | $16.98 | — | COM | 29363K105 |
| SRPT | SAREPTA THERAPEUTICS INC | 100,000 | $1.907M | 0.6% | $18.47 | 0.0% | Call | 803607100 |
| — | INTERCEPT PHARMACEUTICALS IN | 12,700 | $1.812M | 0.5% | $142.68 | — | COM | 45845P108 |
| — | RIGEL PHARMACEUTICALS INC | 800,000 | $1.784M | 0.5% | $2.23 | — | COM NEW | 766559603 |
| VCYT | VERACYTE INC | 341,708 | $1.719M | 0.5% | $8.42 | -36.3% | COM | 92337F107 |
| LAB | FLUIDIGM CORP DEL | 150,000 | $1.355M | 0.4% | $9.40 | 0.0% | COM | 34385P108 |
| — | ALCOBRA LTD | 300,000 | $1.347M | 0.4% | $5.68 | — | SHS | M2239P109 |
| ASND | ASCENDIS PHARMA A S | 100,000 | $1.327M | 0.4% | $13.27 | — | SPONSORED ADR | 04351P101 |
| GILD | GILEAD SCIENCES INC | 15,000 | $1.251M | 0.4% | $62.76 | 0.0% | COM | 375558103 |
| — | TANDEM DIABETES CARE INC | 150,000 | $1.131M | 0.3% | $11.81 | — | COM | 875372104 |
| — | CORBUS PHARMACEUTICALS HLDGS | 300,000 | $897K | 0.3% | $2.99 | — | COM | 21833P103 |
| — | RADIUS HEALTH INC | 20,000 | $735K | 0.2% | $36.75 | — | COM NEW | 750469207 |
| — | MEDIVATION INC | 10,500 | $633K | 0.2% | $60.29 | — | COM | 58501N101 |
| — | AKARI THERAPEUTICS PLC | 46,622 | $629K | 0.2% | $18.60 | — | SPONSORED ADR | 00972G108 |
| — | IMMUNOMEDICS INC | 200,000 | $464K | 0.1% | $2.32 | — | Call | 452907108 |
| HRTX | HERON THERAPEUTICS INC | 25,000 | $451K | 0.1% | $19.73 | -1.1% | COM | 427746102 |
| — | MIRATI THERAPEUTICS INC | 75,000 | $410K | 0.1% | $31.60 | — | COM | 60468T105 |
| — | AEGLEA BIOTHERAPEUTICS INC | 50,000 | $243K | 0.1% | $4.86 | — | COM | 00773J103 |
| — | SYNERGY PHARMACEUTICALS DEL | 22,000 | $84,000 | 0.0% | $3.82 | — | COM NEW | 871639308 |
| — | OCERA THERAPEUTICS INC | 35,801 | $68,000 | 0.0% | $10.04 | — | COM | 67552A108 |